The startup has developed a transdermal and intradermal drug delivery platform utilizing detachable and dissolvable microneedle technology for precise drug dosage and controlled release. This technology enables healthcare companies to enhance the efficacy of medical and cosmetic products by ensuring accurate delivery into the skin.
Funding
$750K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods of drug delivery through the skin can be imprecise, leading to inconsistent dosages and reduced efficacy of medical and cosmetic products. Achieving accurate and controlled release of drugs into the skin layers remains a challenge.
Solution
The startup offers a transdermal and intradermal drug delivery platform that leverages detachable and dissolvable microneedle technology. This platform enables precise drug dosage and controlled release directly into the skin. By utilizing microneedles, the technology ensures accurate delivery, enhancing the efficacy of both medical and cosmetic products. The detachable and dissolvable nature of the microneedles simplifies the application process and eliminates the need for removal, improving patient compliance and reducing potential discomfort. This targeted approach optimizes drug absorption and minimizes systemic exposure, leading to improved therapeutic outcomes.
Target Audience
The primary customers are healthcare companies and cosmetic product manufacturers seeking to improve the delivery and efficacy of their products.
Features
- Detachable microneedles for easy application and removal.
- Dissolvable microneedles that release the drug directly into the skin.
- Precise dosage control for consistent and reliable drug delivery.
- Targeted delivery to specific skin layers (transdermal and intradermal).
- Enhanced drug absorption and bioavailability.
- Reduced systemic exposure compared to traditional methods.